(Q46955169)

26 December 2017

title

Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs (English)

1 reference

26 December 2017

author name string

Bier J

1

1 reference

26 December 2017

Bier H

2

1 reference

26 December 2017

Kleinschuster S

3

1 reference

26 December 2017

Rapp H

4

1 reference

26 December 2017

publication date

1 July 1982

1 reference

26 December 2017

published in

Head & Neck

1 reference

26 December 2017

volume

4

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

457-467

1 reference

26 December 2017

BCG and cancer (first of two parts).

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

C. parvum suppression of rat tumours in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Efficacy of intralesional bcg therapy in guinea pigs with disseminated tumor

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Treatment of primary melanoma by intralesional vaccinia before excision

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Use of Vaccinia Virus in the Treatment of Metastatic Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Immunopotentiation With BeG. I. Immune Response to Different Strains and Preparations2

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Tumor Regression Mediated by Mycobacterium bovis (Strain BCG). Effects of Isonicotinic Acid Hydrazide, Cortisone Acetate, and Antithymocyte Serum

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

BGG immunotherapy of local subcutaneous growths and post-surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Eradication of Microscopic Lymph Node Metastases After Injection of Living BeG Adiacent to the Primary Tumor

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Effective nonliving vaccine against experimental tuberculosis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guérin (BCG)

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Antitumor immunity, V.BCG-induced growth inhibition of murine tumors. Effect of hydrocortisone, antiserum against theta antigen, and gamma-irradiated BCG.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

The influence of immunologically committed lymphoid cells on macrophage activity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

The host response to Calmette-Guérin bacillus infection in mice

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Lymphocyte Mediators and Cellular Hypersensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Macrophage nonimmunologic recognition: target cell factors related to contact inhibition

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Increased cytolytic activity of a subcellular fraction from mouse liver after B.C.G. infection

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

On the mode of action of BCG

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6′-dimycolate)

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hep atoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Immunotherapy with Tumor Cells and BCG in the Guinea Pig, Studied by Immunological In Vivo and In Vitro Experiments

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890040604

7 January 2021

Identifiers

DOI

10.1002/HED.2890040604

1 reference

26 December 2017

1 reference

26 December 2017